Skip to content

Comparing Two Different Amounts of a Drug (Dexmedetomidine) Added to a Numbing Medicine (Bupivacaine) for Better Pain Relief During Arm Surgery Using an Ultrasound-Guided Nerve Block

Comparison of two doses of Dexmedetomidine as an adjuvant to Bupivacaine 0.5% in USG guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095958
Enrollment
99
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: Supraclavicular brachial plexus block: Supraclavicular brachial plexus block will be administered with patient in supine position, patients head will be turned 45 degrees to the opposit

Sponsors

School of medical sciences and research Sharda hospital Sharda university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective upper limb surgery. Age between 18 to 65 years. ASA physical status class 1 and 2

Exclusion criteria

Exclusion criteria: History of allergy or hypersensitivity to local anaesthetic Local infection at the site of injection Refusal to consent Patients with coagulation disorders Pregnancy Morbid obesity History of coronary artery disease, chronic renal and hepatic disease Seizure disorder Psychiatric disease

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of two doses of Dexmedetomidine as an adjuvant to Bupivacaine 0.5% in ultrasound-guided supraclavicular brachial plexus block in upper limb surgeryTimepoint: To compare the duration of analgesia

Secondary

MeasureTime frame
1. To compare the onset and duration of sensory and motor block 2. To compare the rescue analgesic requirements in 24hrs 3.To compare the intraoperative sedation score 4. To compare the intraoperative haemodynamic parameters 5.To compare the incidence of side effects if any Timepoint: Peri operative monitoring till 24hours post operatively

Countries

India

Contacts

Public ContactDr Shaista Jamil

School of medical sciences and research,Sharda university

docshaistajamil@gmail.com8750368756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026